Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- CNCR
- Price
- -
- Stock movement up
- +- (0.00%)
- Company name
- Loncar Cancer Immunotherapy ETF
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Market cap
- -
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- 20.55%
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -38.11%
- 3 year return (CAGR)
- -13.81%
- 5 year return (CAGR)
- -19.18%
- 10 year return (CAGR)
- -
Last updated: 2025-09-02
DIVIDENDS
CNCR does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Stock chart
No data
Stock price data
| Open | 9.02 |
| Daily high | 9.02 |
| Daily low | 9.02 |
| Daily Volume | 0K |
| 1y analyst estimate | - |
| Beta | 0.96 |
| EPS (TTM) | - |
| Dividend per share | 1.85 |
| Ex-div date | 29 Dec 2021 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CNCR | S&P500 | |
| Current price drop from All-time high | -74.73% | -2.75% |
| Highest price drop | -77.56% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -36.25% | -10.86% |
| Avg time to new high | 127 days | 12 days |
| Max time to new high | 1084 days | 1805 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Mid-cap
Description
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index.
Employees
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner